9. Anaphylaxis Journal of Allergy and Clinical Immunology

Slides:



Advertisements
Similar presentations
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Advertisements

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication 
Anaphylaxis: Recent advances in assessment and treatment
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Prospective Evaluation of an Anaphylaxis Education Mini-Handout: The AAAAI Anaphylaxis Wallet Card  Vivian Hernandez-Trujillo, MD, FAAAAI, F. Estelle.
Allergen immunotherapy: A practice parameter third update
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Acute asthma, prognosis, and treatment
Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Auvi-Q Versus EpiPen: Preferences of Adults, Caregivers, and Children
Risk assessment in anaphylaxis: Current and future approaches
F. Estelle R. Simons, MD, FAAAAI, Hugh A. Sampson, MD, FAAAAI 
World Allergy Organization anaphylaxis guidelines: Summary
Is 9 more than 2 also in allergic airway inflammation?
Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis  Mutasem M. Rawas-Qalaji,
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Allergic skin diseases
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
NAEPP Expert Panel Report
Keith J. Simons, PhD, Margherita Strolin Benedetti, PhD, F. Estelle R
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel.
Mark S. Dykewicz, MD  Journal of Allergy and Clinical Immunology 
Peter M. Wolfgram, MD, David B. Allen, MD 
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2  Phillip Lieberman, MD  The Journal of Allergy.
Prospective Evaluation of an Anaphylaxis Education Mini-Handout: The AAAAI Anaphylaxis Wallet Card  Vivian Hernandez-Trujillo, MD, FAAAAI, F. Estelle.
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
Immunopathophysiology of food protein–induced enterocolitis syndrome
A review of the current guidelines for allergic rhinitis and asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Effect of ingested H1 antihistamines on methacholine challenge
What is an “eosinophilic phenotype” of asthma?
Chief Editors: Phillip Lieberman, MD, Stephen F
Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites  Zhikang Peng, MD, Andrew N. Beckett, BSc,
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Aaron M. Drucker, MD, Paula J. Harvey, PhD 
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L
Prevention of food allergy: Beyond peanut
One step forward, 2 steps back: The enigma of preschool wheeze
Anaphylaxis during pregnancy
Epinephrine (adrenaline) absorption from new-generation, taste-masked sublingual tablets: A preclinical study  Ousama Rachid, BPharm, MSc, Mutasem M.
Reply Journal of Allergy and Clinical Immunology
Anaphylaxis Journal of Allergy and Clinical Immunology
Anaphylaxis, killer allergy: Long-term management in the community
Thunderstorm-related asthma attacks
Determinants of systemic manifestations of food allergy
Measles and immunomodulation
Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.
Macrolide antibiotics and asthma treatment
Update on risk factors for food allergy
Asthma: The past, future, environment, and costs
Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD 
Environmental factors and eosinophilic esophagitis
The GILL study: Glycerin-induced local reactions in immunotherapy
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

9. Anaphylaxis Journal of Allergy and Clinical Immunology F. Estelle R. Simons, MD, FRCPC  Journal of Allergy and Clinical Immunology  Volume 121, Issue 2, Pages S402-S407 (February 2008) DOI: 10.1016/j.jaci.2007.08.061 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1A Summary of the pathogenesis of anaphylaxis. Other potential triggers include occupational allergens, inhalants such as horse dander or grass pollen, allergen immunotherapy, vaccines to prevent infectious diseases, hormones, colorants, and enzymes. Some triggers may act through more than 1 mechanism. Individuals with anaphylaxis, by definition, usually have involvement of 2 or more body systems concurrently; the occasional exceptions are those with isolated hypotension after exposure to a known trigger. Journal of Allergy and Clinical Immunology 2008 121, S402-S407DOI: (10.1016/j.jaci.2007.08.061) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1B Summary of anaphylaxis management. Acute treatment is the same regardless of the mechanism or trigger involved in anaphylaxis. In contrast, for long-term risk reduction, avoidance measures and immunomodulation are trigger-specific; currently, immunomodulation is available only for a minority of individuals with anaphylaxis. All at-risk individuals need to have comorbidities and comedications assessed, to be taught the importance of emergency preparedness, and to be instructed in the use of self-injectable epinephrine. ∗The skin should be inspected, and weight estimation is important, especially in infants and children, and also in overweight and obese teens and adults, in order to calculate an optimal dose of epinephrine and other medications needed in treatment and resuscitation. ∗∗Supine position, as tolerated, to prevent empty ventricle syndrome. ∗∗∗Call 911/emergency medical services for anaphylaxis occurring in community healthcare facilities such as medical, dental, or infusion clinics, where optimal backup might not be available for resuscitation. ACLS, Advanced cardiac life support; CPR, cardiopulmonary resuscitation; CVS, cardiovascular; GI, gastrointestinal; ID, identification (eg, bracelet, wallet card); IV, intravenous. Journal of Allergy and Clinical Immunology 2008 121, S402-S407DOI: (10.1016/j.jaci.2007.08.061) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions